Myron Kaplan insider trades
Open-market stock purchases and sales by Myron Kaplan, Director at CorMedix Inc, from SEC Form 4 filings since Apr 28, 2016.
Track record: 89% of 9 scored buys are up 5% or more since purchase, averaging +63%.
Companies traded
- CRMD CorMedix Inc: 18 buys, last Jan 26, 2026